Oleuropein as an inhibitor of peroxisome proliferator-activated receptor gamma

被引:0
|
作者
Michaela Svobodova
Ioanna Andreadou
Alexios-Leandros Skaltsounis
Jan Kopecky
Pavel Flachs
机构
[1] Academy of Sciences of the Czech Republic,Department of Adipose Tissue Biology, Institute of Physiology
[2] v.v.i.,Department of Pharmaceutical Chemistry, School of Pharmacy
[3] University of Athens,Department of Pharmacognosy, School of Pharmacy
[4] University of Athens,undefined
来源
Genes & Nutrition | 2014年 / 9卷
关键词
Oleuropein; Adipogenesis; PPARγ; Olive oil and leaf extracts; Catalase;
D O I
暂无
中图分类号
学科分类号
摘要
Oleuropein, the major phenolic compound found in olive leaves and oil, exerts antioxidant, anti-inflammatory and anti-atherogenic effects and suppresses the adipocyte differentiation in vitro. Herein, we characterized molecular mechanisms underlying the anti-adipogenic effects of oleuropein on 3T3-L1 cells and adipocytes derived from stromal-vascular fraction of dorsolumbar and gonadal fat dissected from mice. We found that oleuropein (>100 μM) decreased viability of preadipocytes proliferating in vitro and did not exerted any cytotoxic effects in post-confluent cells after induction of differentiation. Oleuropein (>100 μM) inhibited adipocyte differentiation, suppressed gene expression of peroxisome proliferator-activated receptor γ (PPARγ), CCAAT-/enhancer-binding protein α, sterol regulatory element-binding transcription factor 1c and fatty acid synthase. Furthermore, we tested ability of oleuropein to regulate of PPARγ-, PPARα- or PPARβ-/PPARδ-mediated β-lactamase expression in appropriate reporter gene assays. Oleuropein between 10 and 400 μM concentrations did not affect activity of PPARα or PPARβ/δ. Contrary, PPARγ activity, either basal or rosiglitazone activated, was inhibited by oleuropein. Our data suggest that oleuropein exerts anti-adipogenic effect through direct inhibition of PPARγ transcriptional activity.
引用
收藏
相关论文
共 50 条
  • [1] Oleuropein as an inhibitor of peroxisome proliferator-activated receptor gamma
    Svobodova, Michaela
    Andreadou, Ioanna
    Skaltsounis, Alexios-Leandros
    Kopecky, Jan
    Flachs, Pavel
    GENES AND NUTRITION, 2014, 9 (01):
  • [2] Leptin and peroxisome proliferator-activated receptor gamma
    Kim, Y. S.
    Kim, H. H.
    Kang, Y. K.
    Moon, J. S.
    Kwon, S. O.
    Oh, M. K.
    Cha, I. H.
    Kim, S. Y.
    Kim, J. N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 110 - 110
  • [3] Peroxisome proliferator-activated receptor gamma in osteoarthritis
    Fahmi, Hassan
    Martel-Pelletier, Johanne
    Pelletier, Jean-Pierre
    Kapoor, Mohit
    MODERN RHEUMATOLOGY, 2011, 21 (01) : 1 - 9
  • [4] Peroxisome proliferator-activated receptor gamma and the control of adipogenesis
    Brun, RP
    Kim, JB
    Hu, E
    Spiegelman, BM
    CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (04) : 212 - 218
  • [5] Dietary modulation of peroxisome proliferator-activated receptor gamma
    Marion-Letellier, R.
    Dechelotte, P.
    Iacucci, M.
    Ghosh, S.
    GUT, 2009, 58 (04) : 586 - 593
  • [6] Ligands for the Nuclear Peroxisome Proliferator-Activated Receptor Gamma
    Sauer, Sascha
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (10) : 688 - 704
  • [7] The role of peroxisome proliferator-activated receptor gamma in prostate cancer
    Elix, Catherine
    Pal, Sumanta K.
    Jones, Jeremy O.
    ASIAN JOURNAL OF ANDROLOGY, 2018, 20 (03) : 238 - 243
  • [8] The localisation of peroxisome proliferator-activated receptor gamma in human bone
    Abu, EO
    Horner, A
    Triffitt, JT
    Compston, JE
    Fraser, WD
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (06) : 1046 - 1046
  • [9] Peroxisome proliferator-activated receptor gamma and leptin receptor in human pregnancy
    Gladstones, GH
    Roberts, P
    HOMO-JOURNAL OF COMPARATIVE HUMAN BIOLOGY, 2003, 54 (01) : 76 - 76
  • [10] Peroxisome proliferator-activated receptor gamma agonists in renal disease
    Iglesias, Pedro
    Diez, Juan J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154 (05) : 613 - 621